The stock of Teladoc Health (NYSE:TDOC, 30-year Financials) appears to be modestly overvalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher. At its current price of $172.35 per share and the market cap of $26.6 billion, Teladoc Health stock shows every sign of being modestly overvalued. GF Value for Teladoc Health is shown in the chart below.
Because Teladoc Health is relatively overvalued, the long-term return of its stock is likely to be lower than its business growth, which averaged 42.1% over the past three years and is estimated to grow 46.60% annually over the next three to five years.
Link: These companies may deliever higher future returns at reduced risk.
Companies with poor financial strength offer investors a high risk of permanent capital loss. To avoid permanent capital loss, an investor must do their research and review a company's financial strength before deciding to purchase shares. Both the cash-to-debt ratio and interest coverage of a company are a great way to to understand its financial strength. Teladoc Health has a cash-to-debt ratio of 0.53, which which ranks in the middle range of the companies in the industry of Healthcare Providers & Services. The overall financial strength of Teladoc Health is 4 out of 10, which indicates that the financial strength of Teladoc Health is poor. This is the debt and cash of Teladoc Health over the past years:
It is less risky to invest in profitable companies, especially those with consistent profitability over long term. A company with high profit margins is usually a safer investment than those with low profit margins. Teladoc Health has been profitable 0 over the past 10 years. Over the past twelve months, the company had a revenue of $1.1 billion and loss of $4.24 a share. Its operating margin is -38.23%, which ranks worse than 84% of the companies in the industry of Healthcare Providers & Services. Overall, the profitability of Teladoc Health is ranked 1 out of 10, which indicates poor profitability. This is the revenue and net income of Teladoc Health over the past years:
Growth is probably the most important factor in the valuation of a company. GuruFocus research has found that growth is closely correlated with the long term stock performance of a company. A faster growing company creates more value for shareholders, especially if the growth is profitable. The 3-year average annual revenue growth of Teladoc Health is 42.1%, which ranks better than 94% of the companies in the industry of Healthcare Providers & Services. The 3-year average EBITDA growth rate is -56.1%, which ranks in the bottom 10% of the companies in the industry of Healthcare Providers & Services.
Another way to look at the profitability of a company is to compare its return on invested capital and the weighted cost of capital. Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business. The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. We want to have the return on invested capital higher than the weighted cost of capital. For the past 12 months, Teladoc Health's return on invested capital is -7.84, and its cost of capital is 3.11. The historical ROIC vs WACC comparison of Teladoc Health is shown below:
Overall, the stock of Teladoc Health (NYSE:TDOC, 30-year Financials) is estimated to be modestly overvalued. The company's financial condition is poor and its profitability is poor. Its growth ranks in the bottom 10% of the companies in the industry of Healthcare Providers & Services. To learn more about Teladoc Health stock, you can check out its 30-year Financials here.
To find out the high quality companies that may deliever above average returns, please check out GuruFocus High Quality Low Capex Screener.
